Neonatal diabetes mellitus due to a novel variant in the INS gene

Sarah E Laurenzano, Cory McFall, Linda Nguyen, Dipal Savla, Nicole G Coufal, Meredith S Wright, Mari Tokita, David Dimmock, Stephen F Kingsmore, Ron S Newfield, Sarah E Laurenzano, Cory McFall, Linda Nguyen, Dipal Savla, Nicole G Coufal, Meredith S Wright, Mari Tokita, David Dimmock, Stephen F Kingsmore, Ron S Newfield

Abstract

Neonatal diabetes mellitus (NDM) is a rare condition that presents with diabetes in the first few months of life. The treatment of NDM may differ depending on the genetic etiology, with numerous studies showing the benefit of sulfonylurea therapy in cases caused by mutations in KCNJ11 or ABCC8 Mutations in the insulin gene (INS) have also been identified as causes of NDM; these cases are generally best treated with insulin alone. We report a case of a female infant born small for gestational age (SGA) at late preterm diagnosed with NDM at 7 wk of life who was found by rapid whole-genome sequencing to harbor a novel de novo c.26C>G (p.Pro9Arg) variant in the INS gene. She presented with diabetic ketoacidosis, which responded to insulin therapy. She did not respond to empiric trial of sulfonylurea therapy early in her hospital course, and it was discontinued once a genetic diagnosis was made. Early genetic evaluation in patients presenting with NDM is essential to optimize therapeutic decision-making.

Trial registration: ClinicalTrials.gov NCT03211039.

Keywords: diabetes mellitus; diabetic ketoacidosis.

© 2019 Laurenzano et al.; Published by Cold Spring Harbor Laboratory Press.

References

    1. Babenko AP, Polak M, Cavé H, Busiah K, Czernichow P, Scharfmann R, Bryan J, Aguilar-Bryan L, Vaxillaire M, Froguel P. 2006. Activating mutations in the ABCC8 gene in neonatal diabetes mellitus. N Engl J Med 355: 456–466. 10.1056/NEJMoa055068
    1. Balboa D, Saarimäki-Vire J, Borshagovski D, Survila M, Lindholm P, Galli E, Eurola S, Ustinov J, Grym H, Huopio H, et al. 2018. Insulin mutations impair β-cell development in a patient-derived iPSC model of neonatal diabetes. Elife 7: e38519 10.7554/eLife.38519
    1. De Franco E, Flanagan SE, Houghton JAL, Allen HL, Mackay DJG, Temple IK, Ellard S, Hattersley AT. 2015. The effect of early, comprehensive genomic testing on clinical care in neonatal diabetes: an international cohort study. Lancet 386: 957–963. 10.1016/S0140-6736(15)60098-8
    1. De León DD, Stanley CA. 2008. Permanent neonatal diabetes mellitus. In GeneReviews® (ed. Adam MP, et al.), pp. 1993–2018. University of Washington, Seattle, WA.
    1. Edghill EL, Flanagan SE, Patch AM, Boustred C, Parrish A, Shields B, Shepherd MH, Hussain K, Kapoor RR, Malecki M, et al. 2008. Insulin mutation screening in 1,044 patients with diabetes: mutations in the INS gene are a common cause of neonatal diabetes but a rare cause of diabetes diagnosed in childhood or adulthood. Diabetes 57: 1034–1042. 10.2337/db07-1405
    1. Farnaes L, Hildreth A, Sweeney NM, Clark MM, Chowdhury S, Nahas S, Cakici JA, Benson W, Kaplan RH, Kronick R, et al. 2018. Rapid whole-genome sequencing decreases infant morbidity and cause of hospitalization. NPJ Genom Med 3: 10 10.1038/s41525-018-0049-4
    1. Iafusco D, Massa O. 2012. Pasquino B, the early diabetes study group of ISPED minimal incidence of neonatal/infancy onset diabetes in Italy is 1:90,000 live births. Acta Diabetol 49: 405–408. 10.1007/s00592-011-0331-8
    1. Konuş OL, Ozdemir A, Akkaya A, Erbaş G, Celik H, Işik S. 1998. Normal liver, spleen, and kidney dimensions in neonates, infants, and children: evaluation with sonography. AJR Am J Roentgenol 171: 1693–1698. 10.2214/ajr.171.6.9843315
    1. Liu M, Hodish I, Haataja L, Lara-Lemus R, Rajpal G, Wright J, Arvan P. 2010. Proinsulin misfolding and diabetes: mutant INS gene–induced diabetes of youth. Trends Endocrinol Metab 21: 652–659. 10.1016/j.tem.2010.07.001
    1. Liu M, Sun J, Cui J, Chen W, Guo H, Barbetti F, Arvan P. 2015. INS-gene mutations: from genetics and β cell biology to clinical disease. Mol Aspects Med 42: 3–18. 10.1016/j.mam.2014.12.001
    1. Oyadomari S, Araki E, Mori M. 2002. Endoplasmic reticulum stress-mediated apoptosis in pancreatic β-cells. Apoptosis 7: 335–345. 10.1023/A:1016175429877
    1. Park JH, Kang JH, Lee KH, Kim NH, Yoo HW, Lee DY, Yoo EG. 2013. Insulin pump therapy in transient neonatal diabetes mellitus. Ann Pediatr Endocrinol Metab 18: 148–151. 10.6065/apem.2013.18.3.148
    1. Pearson ER, Flechtner I, Njølstad PR, Malecki MT, Flanagan SE, Larkin B, Ashcroft FM, Klimes I, Codner E, Iotova V, et al. 2006. Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations. N Engl J Med 355: 467–77. 10.1056/NEJMoa061759
    1. Polak M, Cave H. 2007. Neonatal diabetes mellitus: a disease linked to multiple mechanisms. Orphanet J Rare Dis 2: 12 10.1186/1750-1172-2-12
    1. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, et al. 2015. ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17: 405–424. 10.1038/gim.2015.30
    1. Støy J. 2014. Mutations in the insulin gene [internet]. Diapedia 4105254815 rev 10.14496/dia.4105254815.6
    1. Suzuki S, Koga M. 2014. Glycemic control indicators in patients with neonatal diabetes mellitus. World J Diabetes 5: 198–208. 10.4239/wjd.v5.i2.198
    1. Tubiana-Rufi N. 2007. Insulin pump therapy in neonatal diabetes mellitus. Endocr Dev 12: 67–74. 10.1159/000109606
    1. Wirth M, Jellimann JM, Jellimann S, Hascoët JM. 2018. Neonatal diabetes mellitus: improved screening and early management of an underestimated disease. Clin Case Rep 6: 18–22. 10.1002/ccr3.1276
    1. Yang H, Robinson PN, Wang K. 2015. Phenolyzer: phenotype-based prioritization of candidate genes for human diseases. Nat Methods 12: 841–843. 10.1038/nmeth.3484
    1. Yildiz M, Akcay T, Aydin B, Akgun A, Dogan BB, De Franco E, Ellard S, Onal H. 2018. Emergence of insulin resistance following empirical glibenclamide therapy: a case report of neonatal diabetes with a recessive INS gene mutation. J Pediatr Endocrinol Metab 31: 345–348. 10.1515/jpem-2017-0325

Source: PubMed

Patrocinadores e Colaboradores

Condições médicas

Intervenções de drogas

3
Se inscrever